The Saudi Arabia generic drug market is expected to grow at a CAGR of 8.03% during 2024-2032. Key drivers include favorable government initiatives, rising healthcare costs, patent expirations, the increasing prevalence of chronic diseases, pharmaceutical industry growth, rapid healthcare infrastructure development, and the SFDA's regulatory framework ensuring the safety, quality, and ... https://www.imarcgroup.com/saudi-arabia-generic-drug-market